Eric B Haura Selected Research

Eric B Haura Research Topics

Disease

90	Neoplasms (Cancer) 03/2024 - 11/2002
79	Lung Neoplasms (Lung Cancer) 10/2023 - 07/2003
48	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2023 - 07/2002
16	Adenocarcinoma of Lung 10/2020 - 11/2006
7	Carcinogenesis 03/2015 - 06/2005
6	Neoplasm Metastasis (Metastasis) 01/2023 - 06/2005
5	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2022 - 02/2016
4	Fatigue 01/2022 - 12/2018
4	Melanoma (Melanoma, Malignant) 01/2021 - 01/2017
3	Nausea 01/2023 - 11/2019
3	Sarcoma (Soft Tissue Sarcoma) 01/2018 - 05/2012
3	Adenocarcinoma 01/2015 - 09/2009
2	Hematologic Neoplasms (Hematological Malignancy) 03/2024 - 01/2021
2	Residual Neoplasm 09/2023 - 01/2017
2	Vomiting 01/2023 - 11/2019
2	Pneumonia (Pneumonitis) 01/2022 - 12/2011
2	Thrombocytopenia (Thrombopenia) 01/2021 - 08/2012
2	Breast Neoplasms (Breast Cancer) 01/2021 - 11/2012
2	Small Cell Carcinoma 01/2017 - 07/2003
2	Disease Progression 01/2017 - 05/2008
2	Inflammation (Inflammations) 01/2015 - 12/2011
2	Rhabdomyosarcoma 05/2012 - 09/2009
1	Thrombocytosis (Thrombocythemia) 03/2024
1	Primary Myelofibrosis (Myelosclerosis) 03/2024
1	Polycythemia Vera 03/2024
1	Dyspnea (Shortness of Breath) 01/2023
1	Chills 01/2023

Drug/Important Bio-Agent (IBA)

35	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2003
34	Phosphotransferases (Kinase)IBA 10/2023 - 07/2003
21	ErbB Receptors (EGF Receptor)IBA 11/2023 - 07/2003
16	Tyrosine (L-Tyrosine)FDA Link 01/2023 - 07/2003
13	Tyrosine Kinase InhibitorsIBA 10/2023 - 11/2006
13	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2006
11	Dasatinib (BMS 354825)FDA Link 01/2019 - 06/2006
6	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 03/2024 - 03/2005
6	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2022 - 09/2007
6	RNA (Ribonucleic Acid)IBA 01/2020 - 03/2005
6	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2019 - 04/2010
5	ProteomeIBA 01/2023 - 10/2008
5	Gefitinib (Iressa)FDA Link 01/2022 - 03/2005
5	CytokinesIBA 11/2019 - 07/2003
4	Transforming Growth Factors (Transforming Growth Factor)IBA 06/2021 - 01/2014
4	Anaplastic Lymphoma KinaseIBA 01/2020 - 02/2015
4	VaccinesIBA 03/2019 - 06/2013
4	LigandsIBA 01/2018 - 01/2006
4	Interleukin-6 (Interleukin 6)IBA 07/2014 - 07/2003
4	Transcription Factors (Transcription Factor)IBA 12/2011 - 03/2005
4	src-Family KinasesIBA 07/2010 - 07/2003
4	Epidermal Growth Factor (EGF)IBA 01/2006 - 11/2002
3	AfatinibIBA 11/2023 - 08/2014
3	osimertinibIBA 11/2023 - 01/2021
3	atezolizumabIBA 10/2023 - 10/2022
3	amivantamab-vmjwIBA 10/2023 - 10/2021
3	EnzymesIBA 01/2023 - 07/2013
3	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2023 - 02/2014
3	Peptides (Polypeptides)IBA 01/2023 - 04/2010
3	PlatinumIBA 10/2021 - 09/2010
3	PhosphotyrosineIBA 01/2021 - 10/2010
3	Formaldehyde (Formol)FDA Link 10/2020 - 01/2019
3	Histone Deacetylase InhibitorsIBA 11/2019 - 09/2007
3	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 07/2003
3	Adenosine Triphosphate (ATP)IBA 01/2018 - 02/2016
3	Messenger RNA (mRNA)IBA 12/2017 - 11/2012
3	Doxycycline (Periostat)FDA LinkGeneric 10/2016 - 05/2012
3	AZD 6244IBA 10/2016 - 01/2016
3	Docetaxel (Taxotere)FDA Link 01/2014 - 06/2004
2	NivolumabIBA 07/2023 - 01/2021
2	Immune Checkpoint InhibitorsIBA 01/2023 - 11/2019
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2022 - 12/2016
2	ParaffinIBA 10/2020 - 01/2019
2	Mitogen-Activated Protein KinasesIBA 01/2018 - 04/2010
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2017 - 09/2010
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2016 - 09/2010
2	ChemokinesIBA 08/2016 - 06/2013
2	desthiobiotin (dethiobiotin)IBA 06/2016 - 02/2016
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2016 - 09/2009
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2016 - 01/2015
2	tyrosine receptor (receptor, tyrosine)IBA 10/2015 - 07/2003
2	siltuximabIBA 07/2014 - 03/2011
2	Neutralizing AntibodiesIBA 07/2014 - 03/2011
2	obatoclaxIBA 01/2014 - 03/2008
2	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 09/2012 - 08/2009
2	Cisplatin (Platino)FDA LinkGeneric 09/2009 - 03/2008
2	alvocidib (flavopiridol)IBA 06/2004 - 01/2003
1	lorlatinibIBA 10/2023
1	lazertinibIBA 10/2023
1	IpilimumabIBA 07/2023
1	insulin receptor-related receptor (IRR)IBA 01/2023
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2023
1	Glutathione (Reduced Glutathione)IBA 01/2023
1	DiazomethaneIBA 01/2023
1	IsomerasesIBA 01/2023
1	Pregnenolone Carbonitrile (PCN)IBA 01/2023

Therapy/Procedure

36	Therapeutics 03/2024 - 06/2004
13	Drug Therapy (Chemotherapy) 10/2023 - 07/2002
6	Immunotherapy 01/2020 - 10/2003
3	Secondary Prevention 12/2020 - 01/2016
3	Chemoprevention 09/2014 - 06/2010
2	Adjuvant Chemotherapy 12/2016 - 11/2002
2	Precision Medicine 10/2015 - 08/2012